A multicentre, randomised, double-blind, placebo-controlled, parallel-group trial to evaluate the efficacy and safety of BP1.4979 in adult patients with essential tremor
Essential tremor is a common nervous system condition that causes involuntary shaking, most often in the hands and arms. This clinical trial is testing an experimental medicine called BP1.4979 to see whether it can safely help reduce these tremors. Adults aged 18 and older can take part. Participants will be placed into groups by chance. One group will take the new medicine, while the other will receive a dummy pill, known as a placebo. Neither the patients nor the doctors will know who gets which treatment until the trial ends. The treatment lasts for four weeks. Researchers will measure changes in daily movements, such as writing or holding a cup, using a standard tremor rating scale. The aim is to find out if the new medicine provides meaningful relief and is well tolerated.
Auf einen Blick
Worum geht es in dieser Studie?
Essential tremor is a condition that causes parts of the body, particularly the hands, to shake uncontrollably. For many people, this can make everyday tasks like drinking from a cup, buttoning a shirt, or writing quite difficult. Current treatments do not work well for everyone and can sometimes cause unwanted side effects. Because of this, doctors are searching for new, more effective options.
This trial is looking at an experimental drug known as BP1.4979. It is an early-stage study designed to explore how well the medicine works and check for any side effects. By testing the drug against a placebo (a harmless pill with no active medicine), researchers can be certain that any improvements or side effects are truly caused by the study drug.
Finding a new, safe treatment could improve daily life for many people living with this frustrating condition. By participating, patients help scientists understand whether this new medicine could become a valuable future treatment for essential tremor in the UK and worldwide.
Wichtige Erkenntnisse
- Tests a new medicine, BP1.4979, for people with essential tremor.
- Compares the study drug against a dummy pill (placebo) over four weeks.
- Open to adults aged 18 and over.
- Aims to see if the treatment safely reduces shaking in daily tasks.
- Die Teilnahme ist freiwillig, und Sie können jederzeit zurücktreten.
Wer könnte berechtigt sein?
This study is open to adults aged 18 and over who have been diagnosed with essential tremor. Men and women can both take part.
While the basic criteria are straightforward, the study team will carry out further health checks. They need to ensure that your shaking is definitely caused by essential tremor and not by another condition, such as Parkinson's disease or certain regular medications.
You will also need to be well enough to attend clinic visits and follow the study instructions safely. Your doctor and the trial team will review your full medical history before you can join.
Könnte diese Studie für Sie geeignet sein?
Beantworten Sie diese kurzen Fragen, um zu sehen, ob Sie möglicherweise berechtigt sind. Dies ist nur ein Leitfaden – das Forschungsteam trifft die endgültige Entscheidung.
- I am at least 18 years old.
- I have been diagnosed with essential tremor.
- My tremor affects my hands, arms, or daily activities.
- I am willing to take a daily study tablet for four weeks.
- I can attend regular hospital or clinic appointments for check-ups.
Was beinhaltet die Teilnahme?
If you decide to take part, you will first visit the clinic for screening tests to check if the trial is right for you. If accepted, you will be randomly assigned to take either the study drug (BP1.4979) or a matching placebo pill every day for four weeks.
During these four weeks, you will attend regular clinic appointments. At these visits, doctors will check your blood pressure, monitor your general health, and ask about any side effects. They will also ask you to perform simple physical tasks—like drawing shapes, drinking water, or holding your arms outstretched—to measure your tremor severity using an official scale.
In total, taking part will last around a month of active treatment, plus the initial screening and possibly a short follow-up check afterwards. The research team will support you throughout the process.
Potenzielle Risiken und Vorteile
Standorte (1)
- —UnbestätigtFrankreich
Häufige Fragen
Was ist ein Placebo?
A placebo is a dummy pill that looks just like the real medicine but contains no active ingredients. It helps researchers prove whether the study drug truly works.
Will I know if I am taking the real medicine?
No. This is a double-blind trial, meaning neither you nor your study doctors will know which pill you are taking until the entire study is finished.
Can I carry on taking my usual medicines?
You must discuss your current prescriptions with the trial team. Some medications might need to stay at a steady dose, while others might not be allowed during the trial.
Do I have to pay to take part?
No, clinical trials do not charge patients. The study medicine and all trial-related tests are provided free of charge, and travel expenses are often reimbursed.
Was passiert, wenn ich meine Meinung ändere?
You can withdraw from the trial at any time. Doing so will not affect your relationship with your doctors or the standard of care you receive.
Wie Sie mehr erfahren können
Sprechen Sie immer mit Ihrem Hausarzt oder Spezialisten, bevor Sie sich entscheiden, an einer Studie teilzunehmen.
Interessiert daran, teilzunehmen?
Diskussion
Community-Diskussion
Bereitgestellt von unserem Forum bei community.patient.info. Bitte seien Sie respektvoll — dies ist kein medizinischer Rat.